Diagnostics To Be Treated Same As Devices Under UDI Program, FDA Says

Manufacturers of in vitro diagnostics will be required to take part in FDA’s forthcoming Unique Device Identification (UDI) program, an agency official says.

More from Archive

More from Medtech Insight